416375002: Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product (product)\Medicinal product (product)\...

\Medicinal product categorized by disposition (product)\Product containing tobramycin (medicinal product)\...

\Product containing tobramycin in ocular dose form (medicinal product form)\Product containing loteprednol and tobramycin in ocular dose form (medicinal product form)\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension

\Product containing loteprednol and tobramycin (medicinal product)\Product containing loteprednol and tobramycin in ocular dose form (medicinal product form)\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension
\Product containing loteprednol and tobramycin (medicinal product)\Loteprednol and tobramycin only product\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension

\Medicinal product categorized by structure\Product containing steroid (product)\Product containing androstane (product)\Product containing loteprednol (medicinal product)\Product containing loteprednol and tobramycin (medicinal product)\Product containing loteprednol and tobramycin in ocular dose form (medicinal product form)\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension
\Medicinal product categorized by structure\Product containing steroid (product)\Product containing androstane (product)\Product containing loteprednol (medicinal product)\Product containing loteprednol and tobramycin (medicinal product)\Loteprednol and tobramycin only product\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension
\Medicinal product categorized by structure\Product containing steroid (product)\Product containing androstane (product)\Product containing loteprednol (medicinal product)\Product containing loteprednol in ocular dose form (medicinal product form)\Product containing loteprednol and tobramycin in ocular dose form (medicinal product form)\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension
\Medicinal product categorized by structure\Product containing steroid (product)\Corticosteroid and/or corticosteroid derivative-containing product\Product containing glucocorticoid (product)\Product containing loteprednol (medicinal product)\Product containing loteprednol and tobramycin (medicinal product)\Product containing loteprednol and tobramycin in ocular dose form (medicinal product form)\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension
\Medicinal product categorized by structure\Product containing steroid (product)\Corticosteroid and/or corticosteroid derivative-containing product\Product containing glucocorticoid (product)\Product containing loteprednol (medicinal product)\Product containing loteprednol and tobramycin (medicinal product)\Loteprednol and tobramycin only product\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension
\Medicinal product categorized by structure\Product containing steroid (product)\Corticosteroid and/or corticosteroid derivative-containing product\Product containing glucocorticoid (product)\Product containing loteprednol (medicinal product)\Product containing loteprednol in ocular dose form (medicinal product form)\Product containing loteprednol and tobramycin in ocular dose form (medicinal product form)\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension
\Medicinal product categorized by structure\Product containing glycoside (product)\Product containing aminoglycoside (product)\Aminoglycoside antibacterial agent\Product containing tobramycin (medicinal product)\Product containing tobramycin in ocular dose form (medicinal product form)\Product containing loteprednol and tobramycin in ocular dose form (medicinal product form)\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension
\Medicinal product categorized by structure\Product containing glycoside (product)\Product containing aminoglycoside (product)\Aminoglycoside antibacterial agent\Product containing tobramycin (medicinal product)\Product containing loteprednol and tobramycin (medicinal product)\Product containing loteprednol and tobramycin in ocular dose form (medicinal product form)\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension
\Medicinal product categorized by structure\Product containing glycoside (product)\Product containing aminoglycoside (product)\Aminoglycoside antibacterial agent\Product containing tobramycin (medicinal product)\Product containing loteprednol and tobramycin (medicinal product)\Loteprednol and tobramycin only product\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension

\Medicinal product categorised by therapeutic role\Medicinal product acting as antiinfective agent (product)\Medicinal product acting as antibacterial agent (product)\Aminoglycoside antibacterial agent\Product containing tobramycin (medicinal product)\...

\Product containing tobramycin in ocular dose form (medicinal product form)\Product containing loteprednol and tobramycin in ocular dose form (medicinal product form)\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension

\Product containing loteprednol and tobramycin (medicinal product)\Product containing loteprednol and tobramycin in ocular dose form (medicinal product form)\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension
\Product containing loteprednol and tobramycin (medicinal product)\Loteprednol and tobramycin only product\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension

\Product manufactured as ocular dose form (product)\Product containing tobramycin in ocular dose form (medicinal product form)\Product containing loteprednol and tobramycin in ocular dose form (medicinal product form)\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension
\Product manufactured as ocular dose form (product)\Product containing loteprednol in ocular dose form (medicinal product form)\Product containing loteprednol and tobramycin in ocular dose form (medicinal product form)\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3762275019 Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

3762276018 Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

4608061000052117 loteprednoletabonat 5 milligram/milliliter och tobramycin 3 milligram/milliliter, suspension för oftalmiskt bruk sv Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Sweden NRC maintained module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Is a	loteprednoletabonat + tobramycin	false	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Has active ingredient	Corticosterone	false	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Has active ingredient	binjurehormonmedel	false	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Has active ingredient	Tobramycin (substance)	false	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Has active ingredient	Loteprednol etabonate (substance)	false	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Has active ingredient	Glucocorticoid hormone	false	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Has active ingredient	Bactericide	false	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Has manufactured dose form	Ocular dose form (dose form)	false	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Is a	loteprednoletabonat för oftalmiskt bruk	false	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Is a	tobramycin för oftalmiskt bruk	false	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Has manufactured dose form	Eye suspension	true	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Is a	Product containing loteprednol and tobramycin (medicinal product)	false	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Is a	Product containing loteprednol in ocular dose form (medicinal product form)	false	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Is a	TEMPORARY parent for CDs that are not updated	false	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Has concentration strength denominator unit	mL	true	Inferred relationship	Some	1
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Has concentration strength numerator unit	mg	true	Inferred relationship	Some	2
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	räkning av bas i aktiv ingrediens	2 (qualifier value)	false	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Has concentration strength denominator unit	mL	true	Inferred relationship	Some	2
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Has concentration strength numerator unit	mg	true	Inferred relationship	Some	1
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	har nämnarvärde som visar koncentrationsstyrka	1 (qualifier value)	false	Inferred relationship	Some	1
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	har nämnarvärde som visar koncentrationsstyrka	1 (qualifier value)	false	Inferred relationship	Some	2
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Is a	Loteprednol and tobramycin only product in ocular dose form	true	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Has precise active ingredient	Loteprednol etabonate (substance)	true	Inferred relationship	Some	2
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Has precise active ingredient	Tobramycin (substance)	true	Inferred relationship	Some	1
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Has basis of strength substance (attribute)	Tobramycin (substance)	true	Inferred relationship	Some	1
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	har täljarvärde för koncentrationsstyrka	5 (qualifier value)	false	Inferred relationship	Some	2
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	har täljarvärde för koncentrationsstyrka	3 (qualifier value)	false	Inferred relationship	Some	1
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Has basis of strength substance (attribute)	Loteprednol etabonate (substance)	true	Inferred relationship	Some	2
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Plays role	Antibacterial therapeutic role (role)	true	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Is a	Product containing glucocorticoid (product)	false	Inferred relationship	Some

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3762275019	Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
3762276018	Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
4608061000052117	loteprednoletabonat 5 milligram/milliliter och tobramycin 3 milligram/milliliter, suspension för oftalmiskt bruk	sv	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Sweden NRC maintained module (core metadata concept)